Veterinary Medicines

E-SELENSOL 70/1 mg/ml emulsion for injection for cattle, sheep and pigs

Authorised
  • ALPHA-TOCOPHEROL
  • Sodium selenite
Download as PDF

Product identification

Medicine name:
E-SELENSOL 70/1 mg/ml emulsion for injection for cattle, sheep and pigs
E-SELENSOL 70/1 mg/ml ενέσιμο γαλάκτωμα για βοοειδή, πρόβατα και χοίρους
Active substance:
  • ALPHA-TOCOPHEROL
  • Sodium selenite
Target species:
  • Cattle
  • Pig
  • Sheep
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • ALPHA-TOCOPHEROL
    70.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sodium selenite
    1.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        14
        day
    • Pig
      • Meat and offal
        14
        day
    • Sheep
      • Meat and offal
        30
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        14
        day
    • Pig
      • Meat and offal
        14
        day
    • Sheep
      • Meat and offal
        30
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12CE99
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:
  • Type II amber coloured glass vials, with bromobutyl rubber stopper and lacquered aluminium cap. Carton box with 1 vial of 50 ml.
  • Type II amber coloured glass vials, with bromobutyl rubber stopper and lacquered aluminium cap. Carton box with 1 vial of 100 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic (abridged application) - art 13(1)
Marketing authorisation holder:
  • Labiana Life Sciences S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 152794/28-07-2021 (K-0243601)
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/0143/001
Concerned member states:
  • Croatia
  • Cyprus
  • Estonia
  • Greece
  • Latvia
  • Lithuania

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 2/06/2022
Download